The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Herpes Genitalis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Herpes Genitalis


Psychiatry related information on Herpes Genitalis


High impact information on Herpes Genitalis


Chemical compound and disease context of Herpes Genitalis


Biological context of Herpes Genitalis


Anatomical context of Herpes Genitalis


Gene context of Herpes Genitalis


Analytical, diagnostic and therapeutic context of Herpes Genitalis


  1. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. Reichman, R.C., Badger, G.J., Mertz, G.J., Corey, L., Richman, D.D., Connor, J.D., Redfield, D., Savoia, M.C., Oxman, M.N., Bryson, Y. JAMA (1984) [Pubmed]
  2. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus. Ashley, R.L., Corey, L. J. Clin. Invest. (1984) [Pubmed]
  3. Intravenous acyclovir for the treatment of primary genital herpes. Corey, L., Fife, K.H., Benedetti, J.K., Winter, C.A., Fahnlander, A., Connor, J.D., Hintz, M.A., Holmes, K.K. Ann. Intern. Med. (1983) [Pubmed]
  4. Antiviral activity and dose optimum of recombinant macrophage colony-stimulating factor on herpes simplex genitalis in guinea pigs. Ho, R.J., Chong, K.T., Merigan, T.C. J. Immunol. (1991) [Pubmed]
  5. Trends in HIV seroprevalence in men who have sex with men: New York City Department of Health sexually transmitted disease clinics, 1988-1993. Torian, L.V., Weisfuse, I.B., Makki, H.A., Benson, D.A., DiCamillo, L.M., Patel, P.R., Toribio, F.E. AIDS (1996) [Pubmed]
  6. Psychological and psychosexual implications of herpes simplex virus infections. Mindel, A. Scandinavian journal of infectious diseases. Supplementum. (1996) [Pubmed]
  7. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. Wald, A., Zeh, J., Selke, S., Warren, T., Ryncarz, A.J., Ashley, R., Krieger, J.N., Corey, L. N. Engl. J. Med. (2000) [Pubmed]
  8. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. Kost, R.G., Hill, E.L., Tigges, M., Straus, S.E. N. Engl. J. Med. (1993) [Pubmed]
  9. Nonoxynol 9 cream for genital herpes simplex. Donsky, H.J. N. Engl. J. Med. (1979) [Pubmed]
  10. Carbocyclic arabinofuranosyladenine (cyclaradine): efficacy against genital herpes in guinea pigs. Vince, R., Daluge, S., Lee, H., Shannon, W.M., Arnett, G., Schafer, T.W., Nagabhushan, T.L., Reichert, P., Tsai, H. Science (1983) [Pubmed]
  11. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Diaz-Mitoma, F., Sibbald, R.G., Shafran, S.D., Boon, R., Saltzman, R.L. JAMA (1998) [Pubmed]
  12. Famciclovir for genital herpes. Goldman, B.D. JAMA (1997) [Pubmed]
  13. The use of 2-deoxy-D-glucose for genital herpes. Corey, L., Holmes, K.K. JAMA (1980) [Pubmed]
  14. Topical idoxuridine in the treatment of genital herpes. Rozman, T.A., Wiedey, K.D. JAMA (1983) [Pubmed]
  15. Ineffectiveness of topical idoxuridine in dimethyl sulfoxide for therapy for genital herpes. Silvestri, D.L., Corey, L., Holmes, K.K. JAMA (1982) [Pubmed]
  16. Successful treatment of human genital herpes infections with 2-deoxy-D-glucose. Blough, H.A., Giuntoli, R.L. JAMA (1979) [Pubmed]
  17. A trial of topical acyclovir in genital herpes simplex virus infections. Corey, L., Nahmias, A.J., Guinan, M.E., Benedetti, J.K., Critchlow, C.W., Holmes, K.K. N. Engl. J. Med. (1982) [Pubmed]
  18. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. Straus, S.E., Takiff, H.E., Seidlin, M., Bachrach, S., Lininger, L., DiGiovanna, J.J., Western, K.A., Smith, H.A., Lehrman, S.N., Creagh-Kirk, T. N. Engl. J. Med. (1984) [Pubmed]
  19. Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. Stanberry, L.R., Kit, S., Myers, M.G. J. Virol. (1985) [Pubmed]
  20. Effect of acyclovir on genital herpes in guinea pigs. Pronovost, A.D., Lucia, H.L., Dann, P.R., Hsiung, G.D. J. Infect. Dis. (1982) [Pubmed]
  21. Oral acyclovir and recurrent genital herpes during late pregnancy. Haddad, J., Langer, B., Astruc, D., Messer, J., Lokiec, F. Obstetrics and gynecology. (1993) [Pubmed]
  22. Isopentenyl pyrophosphate-reactive Vgamma9Vdelta 2 T helper 1-like cells are the major gammadelta T cell subset recovered from lesions of patients with genital herpes. Verjans, G.M., Roest, R.W., van der Kooi, A., van Dijk, G., van der Meijden, W.I., Osterhaus, A.M. J. Infect. Dis. (2004) [Pubmed]
  23. Herpes simplex virus 2-associated hemophagocytic lymphohistiocytosis in a pregnant patient. Yamaguchi, K., Yamamoto, A., Hisano, M., Natori, M., Murashima, A. Obstetrics and gynecology. (2005) [Pubmed]
  24. Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient. Bernhard, P., Obel, N. Scand. J. Infect. Dis. (1995) [Pubmed]
  25. Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection. Svensson, A., Kaim, J., Mallard, C., Olsson, A., Brodin, E., Hökfelt, T., Eriksson, K. J. Immunol. (2005) [Pubmed]
  26. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. Ashkar, A.A., Rosenthal, K.L. J. Virol. (2003) [Pubmed]
  27. Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection. Singh, R., Kumar, A., Creery, W.D., Ruben, M., Giulivi, A., Diaz-Mitoma, F. Clin. Exp. Immunol. (2003) [Pubmed]
  28. Analysis of the interferon status and cytokine profile in patients with genital herpes. Mezentseva, M.V., Narovlyansky, A.N., Scherbenko, V.E., Polonsky, V.O., Anokhina, E.Y., Ershov, F.I. Russ. J. Immunol. (2002) [Pubmed]
  29. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet. Svensson, A., Nordström, I., Sun, J.B., Eriksson, K. J. Immunol. (2005) [Pubmed]
  30. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. Reitano, M., Tyring, S., Lang, W., Thoming, C., Worm, A.M., Borelli, S., Chambers, L.O., Robinson, J.M., Corey, L. J. Infect. Dis. (1998) [Pubmed]
  31. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Perry, C.M., Faulds, D. Drugs (1996) [Pubmed]
  32. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Ashley-Morrow, R., Krantz, E., Wald, A. Sexually transmitted diseases. (2003) [Pubmed]
  33. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes. Morrow, R.A., Friedrich, D., Krantz, E. J. Clin. Microbiol. (2003) [Pubmed]
  34. Herpes simplex virus type 1 remains the principal cause of initial anogenital herpes in Edinburgh, Scotland. Manavi, K., McMillan, A., Ogilvie, M. Sexually transmitted diseases. (2004) [Pubmed]
WikiGenes - Universities